RetaMaps

How to choose a weight-loss doctor (and the red flags to walk away from)

RetaMaps Editorial· Updated October 2, 2026· Editorial review · Medical review pending
Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs

If retatrutide brought you here, the most useful thing you can do before it arrives is the same thing you'd do after: find a clinician who treats weight seriously and will still be your doctor when the options change. Here's how to evaluate one — and the red flags that should end a visit early.

Credentials that actually mean something

  • ABOM diplomate. The American Board of Obesity Medicine certifies physicians who pass an exam in obesity medicine on top of their primary board. It's the clearest single signal that weight management is a studied focus, not a sideline.
  • Board-certified endocrinologist. Endocrinology covers the hormonal systems these drugs act on; endocrinologists are a natural fit for complex metabolic cases and for patients with diabetes or thyroid disease.
  • Bariatric programs. Surgical-weight-loss centers typically run medical (non-surgical) programs too, with dietitians and follow-up infrastructure built in.
  • Primary care with a real program. Plenty of family-medicine and internal-medicine practices run structured weight-management programs. The structure — scheduled follow-ups, labs, dose management — matters more than the specialty on the door.

On RetaMaps provider profiles, we show the service signals we can verify from public information, and our listings exclude practices that sell or promote illicit retatrutide. You can search providers near you by city and state.

Questions to ask at a first visit

  1. "How do you decide which medication fits me?" You want to hear about your history, conditions, insurance reality, and goals — not a single house protocol everyone gets.
  2. "What does follow-up look like?" Dose escalation, side-effect management, and labs are where outcomes are made. Monthly-ish contact during titration is a good sign.
  3. "What happens if a medication doesn't work for me, or I can't stay on it?" Good programs have a plan B — and a plan for maintenance, not just loss.
  4. "Where do your prescriptions get filled?" FDA-approved products from licensed pharmacies is the only right answer.
  5. "What's your view on retatrutide?" The accurate answer today: it's investigational, Phase 3 results are strong, access is limited to trials and Lilly's physician-requested expanded access program [1] [4] — and here's what we'd do in the meantime. A clinician who tells you that is being straight with you. One who says they can get it now is not.

Red flags that should end the conversation

  • "Research peptides" on the menu. Any clinic selling or recommending "research use only" compounds is operating in the gray market the FDA is actively warning about. [2]
  • "We can get you reta now." No legitimate provider can. Lilly's August 2026 lawsuits named a med spa and a compounding pharmacy among the defendants — clinic signage doesn't make the product real. [3]
  • Prescribing without an exam. A questionnaire-only "consult" that ends in an injection, with no history, vitals, labs when indicated, or contraindication screening, is a sales funnel.
  • No interest in your medical history. These medications have real contraindications and interactions; a provider who doesn't ask isn't managing them.
  • Prepaid long-term packages for a specific drug. Treatment plans change; large prepayments lock you in before anyone knows the medication suits you.
  • Guarantees. Specific weight-loss promises aren't medicine.

If a listed provider shows any of these, please report the listing — compliance screening is central to how this directory works, and reports feed it. See also what we don't list.

Telehealth: the licensing basics

Telehealth is a legitimate and often excellent way to get weight-loss care, with two structural checks:

  • State licensing. Clinicians must generally be licensed in the state where you are located during the visit. Reputable telehealth programs verify your state and route you to a licensed clinician; storefronts that never ask are telling you something.
  • Pharmacy dispensing. Prescriptions should be filled by licensed pharmacies. A telehealth brand that ships its own unbranded vials — particularly anything labeled "research" — fails the check regardless of how polished the website is. [2]

The bottom line

Choose the clinician you'd want managing your care for years, not the one promising the newest drug fastest. The provider who gives you an accurate answer about retatrutide today — investigational, trials and expanded access only [1] — is the one worth keeping when it (projected) reaches the market. Find providers near you, and for the drug's actual status as it develops, follow the FDA approval tracker or get email updates.

Sources

  1. Lilly — What to know about retatrutide (updated July 2026)
  2. FDA — Concerns with unapproved GLP-1 drugs
  3. CNBC — Lilly sues sellers of illicit retatrutide (Aug 12, 2026)
  4. STAT — Lilly's expanded access program (Aug 3, 2026)

FAQs

Do I need an obesity-medicine specialist, or is my primary care doctor enough?

Many primary care physicians prescribe GLP-1 medications well. A specialist (ABOM diplomate, endocrinologist, or a dedicated obesity-medicine clinic) earns their keep when your case is complex — multiple conditions, prior medication failures, bariatric surgery history, or interest in trials and expanded access.

Is telehealth weight-loss care legitimate?

It can be, when the clinician is licensed in your state, takes a real history, orders or reviews labs when indicated, and prescribes FDA-approved medications through licensed pharmacies. The structure — not the format — is what separates telehealth care from a vial-shipping storefront.

Can any doctor get me retatrutide?

No doctor can prescribe it today — it's investigational. A physician's only routes are referring you to a clinical trial or submitting an expanded access request to Lilly on your behalf. Anyone offering it any other way is a red flag, not a connection.

Find weight-loss providers near you

Browse the practices RetaMaps tracks, or get an email when retatrutide's status changes.

Get updates